• CAO, C., CIRAUQUI, N., MARCAIDA, M.J., BUGLAKOVA, E., DUPERREX, A., RADENOVIC, A., DAL PERARO, M. Aerolysin nanopore sensing is controlled at the double β-barrel cap. Accepted for publication in Nature Communications.​

​

• CIRAUQUI, N., ABRIATA, L., VAN DER GOOT, G., DAL PERARO, M. Structural, physicochemical and dynamic features conserved within the aerolysin pore-forming toxin Family. Scientific Reports 7: 13932, 2017.

​

• MORENO-VIGURI, E., JIMÉNEZ-MONTES, C., MARTÍN-ESCOLANO, R., SANTIVAÑEZ-VELIZ, M., MARTIN-MONTES, A., AZQUETA, A., JIMENEZ-LOPEZ, M., ZAMORA LEDESMA, S., CIRAUQUI, N., LÓPEZ DE CERÁIN, A., MARÍN, C., SÁNCHEZ-MORENO, M., PÉREZ-SILANES, S. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives. J Med Chem. 59(24):10929-10945, 2016.

​

• BAEZ, C.F., BAREL, V.A., DE SOUZA, A.M., RODRIGUES, C.R., VARELLA, R.B., CIRAUQUI, N. Analysis of worldwide sequence mutations in Zika virus proteins E, NS1, NS3 and NS5 from a structural point of view. Mol Biosyst.13(1):122-131, 2016.

​

• IACOVACHE, I., DE CARLO, S., CIRAUQUI, N., DAL PERARO, M.,; VAN DER GOOT, F. G., ZUBER, B. Cryo-EM structure of aerolysin variants reveals a novel protein fold and the pore-formation process. Nature Communications. , v.7, p.12062 - , 2016.

​

• SOUSA, A. C., VIANA, G. M., DIAZ, N. C., REZENDE, M. G., OLIVEIRA, F. F., NUNES, R. P., PEREIRA, M. F., AREAS, A. L. L., ZALIS, M. G., FRUTUOSO, V. S., FARIA, H. C., DOMINGOS, T. F. S., PÁDULA, M.. CABRAL, L. M., RODRIGUES, C. R. Design, Synthesis and Evaluation of New Fluoroamodiaquine Analogues. Chemical and Pharmaceutical Bulletin., v.64, p.594 - 601, 2016.

​

• BAEZ, C. F., DIAZ, N. C., VENCESLAU, M. T., LUZ, F. B.; GUIMARÃES, M. A. A. M., ZALIS, M. G., VARELLA, R. B. Phylogenetic and structural analysis of merkel cell polyomavirus VP1 in Brazilian samples. Virus Research (Print). , v.221, p.1 - 7, 2016.

​

• CARDOSO, K. M., DIAZ, NURIA C., GUIMARÃES, M. A. A. M., ZALIS, M. G., DELBUE, S.; FERRANTE, P.; VARELLA, R. B. Genetic and structural analysis of polyomavirus BK T-antigens reveal a higher density of mutations at inter-domain and hexamerization regions, regardless the status of infection. Journal of Medical Virology (Print). , v.87, p.n/a - n/a, 2015.

​

• DE SOUSA, A. C. C., DIAZ, N. C., DE SOUZA, A. M. T., CABRAL, L. M., CASTRO, H. C., ALBUQUERQUE, M. G., RODRIGUES, C. R. Molecular modeling study of a series of amodiaquine analogues with antimalarial activity. Medicinal Chemistry Research (Print). , v.24, p.3529 - 3536, 2015.

​

• FREZE BAEZ, C.; CIRAUQUI DIAZ, N.; BAETA CAVALCANTI, S. M.; BRANDÃO VARELLA, R. Genetic and Structural Analysis of Merkel Cell Polyomavirus Large T Antigen from Diverse Biological Samples. Intervirology. , v.57, p.331 - 336, 2014.

​

• CERAS, J., CIRAUQUI, N., PÈREZ-SILANES, S., ALDANA, I., MONGE, A., GALIANO, S. Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies. European Journal of Medicinal Chemistry, v. 52, p. 1 - 13, 2012.

​

• CIRAUQUI, N., SCHREY, A., GALIANO, S., CERAS, J., PEREZ-SILANES, S., ALDANA, I., MONGE, A., KÜHNE, R. Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents. Bioorganic & Medicinal Chemistry (Print), v. 18, p. 7365- 7379, 2010.

​

• RIVERA, G., BOCANEGRA-GARCÍA, V., GALIANO, S., CIRAUQUI, N., CERAS, J., PÈREZ-SILANES, S., ALDANA, I., MONGE, A. Melanin-Concentrating Hormone Receptor 1 Antagonists: A New Perspective for the Pharmacologic Treatment of Obesity. Current Medicinal Chemistry (Hilversum), v. 15, p. 1025 - 1043, 2008.

​

• CIRAUQUI, N., CERAS, J., GALIANO, S., PÈREZ-SILANES,S., JUANENEA, L., RIVERA, G., ALDANA,I., MONGE, A. New amide derivatives as melaninconcentrating hormone receptor 1 antagonists for the treatment of obesity. Arzneimittel Forschung, v. 58, p. 585 - 591, 2008.

​

• GALIANO, S., CERAS, J., CIRAUQUI, N., PÈREZ, S., JUANENEA, L., RIVERA, G., ALDANA, I., MONGE, A. Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry, v. 15, p. 3896 - 3911, 2007.